Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study

Abstract It remains uncertain whether the hypertension (HT) medications angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) mitigate or exacerbate SARS‐CoV‐2 infection. We evaluated the association of ACEi and ARB with severe coronavirus disease 19 (COVID‐19) as d...

Full description

Bibliographic Details
Main Authors: Ann Z. Bauer, Rebecca Gore, Susan R. Sama, Richard Rosiello, Lawrence Garber, Devi Sundaresan, Anne McDonald, Patricia Arruda, David Kriebel
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:The Journal of Clinical Hypertension
Subjects:
angiotensin receptor blockers
angiotensin‐converting enzyme inhibitors
COVID‐19
hypertension
renin–angiotensin system
Online Access:https://doi.org/10.1111/jch.14101

Internet

https://doi.org/10.1111/jch.14101

Similar Items